95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.14%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.47%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-7.96%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-7.96%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-5.12%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.05%
Share reduction more than 1.5x RGLD's 0.60%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.31%
Diluted share count expanding well above RGLD's 0.70%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-14.11%
Negative OCF growth while RGLD is at 138.23%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-14.11%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
46.59%
10Y revenue/share CAGR under 50% of RGLD's 578.02%. Michael Burry would suspect a lasting competitive disadvantage.
24.76%
5Y revenue/share CAGR under 50% of RGLD's 272.79%. Michael Burry would suspect a significant competitive gap or product weakness.
36.40%
3Y revenue/share CAGR under 50% of RGLD's 78.93%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
216.23%
Below 50% of RGLD's 648.30%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-45.21%
Negative 3Y OCF/share CAGR while RGLD stands at 99.50%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
219.86%
3Y net income/share CAGR above 1.5x RGLD's 89.21%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
196.05%
Below 50% of RGLD's 848.16%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
188.63%
Below 50% of RGLD's 675.00%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
291.55%
3Y equity/share CAGR 1.25-1.5x RGLD's 207.55%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.63%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
4.08%
Asset growth well under 50% of RGLD's 57.92%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.14%
Under 50% of RGLD's 61.10%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.33%
We cut SG&A while RGLD invests at 10.62%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.